approval
saveEPYSQLI (ECULIZUMAB-AAGH) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 23, 2026 · 261d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 28, 2025 · 317d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025 · 335d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalSep 2, 2025 · 404d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalMar 12, 2025 · 578d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025 · 621d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 21, 2025 · 628d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 15, 2024 · 695d ago
same company · ±60 days · 6
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025
- approvalOPUVIZ: OPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalJun 6, 2025
comments(0)
5-min edit window · permanent after that